Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Margin

    Back to All Ratios
AARTI PHARMALABS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 21.9620.8417.5817.11-

What is the latest Core EBITDA Margin ratio of AARTI PHARMALABS ?

The latest Core EBITDA Margin ratio of AARTI PHARMALABS is 21.96 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202521.96
Mar202420.84
Mar202317.58
Mar202217.11
Mar2021-

How is Core EBITDA Margin of AARTI PHARMALABS Trending?

Years Core EBITDA Margin % Change
Mar2025 21.96
5.37
Mar2024 20.84
18.54
Mar2023 17.58
2.75
Mar2022 17.11
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Margin ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹8,159.0 Cr -1.2% 4.9% 41.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,451.0 Cr 2.1% 0.3% -9.6% Stock Analytics
DIVIS LABORATORIES ₹161,727.0 Cr -0% 1.1% 13.4% Stock Analytics
CIPLA ₹124,533.0 Cr -1.1% -3.2% -4.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,673.0 Cr 3.4% 0.2% 8.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,629.0 Cr -0.7% 2% 0.7% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-1.2%

4.9%

41.5%

SENSEX

0.5%

0.4%

-1.1%


You may also like the below Video Courses